Ralph Lipp has become the founding member of the Catalent Applied Drug Delivery Institute’s advisory board.
Lipp brings more than 20 years of industry and academic experience to the role, having previously held the position of Vice President, Pharmaceutical Sciences R&D at Eli Lilly and R&D leadership roles at Schering. His broad research experience includes oncology, cardiovascular disease, central nervous system disorders, women’s health, in vivo diagnostics and dermatology.
The Institute was established last year to accelerate the adoption of advanced drug delivery technologies through industry and academic collaboration, research, education, and the sharing of information.
